-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 47c; raises guidance
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Tops Q4 EPS by 25c
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 63c
-
-
-
-
-
-
-
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $210 at Needham
-
-
-
-
-
-
-
Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024
-
-
-
-
-
-
-
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
-
1,233,859 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


